Compounds > 4-diphenylacetoxy-1,1-dimethylpiperidinium
Page last updated: 2024-10-21

4-diphenylacetoxy-1,1-dimethylpiperidinium and Anoxemia

4-diphenylacetoxy-1,1-dimethylpiperidinium has been researched along with Anoxemia in 1 studies

4-diphenylacetoxy-1,1-dimethylpiperidinium: muscarinic receptor antagonist; RN given refers to parent cpd; do not confuse abbreviation 4-DAMP with a similar cpd which does not contain dimethyl groups
4-DAMP(1+) : A quaternary ammonium salt obtained by formal methylation of the tertiary amino function of 4-diphenylacetoxy-N-methylpiperidine.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fischer, LG1
Horstman, DJ1
Hahnenkamp, K1
Kechner, NE1
Rich, GF1

Other Studies

1 other study available for 4-diphenylacetoxy-1,1-dimethylpiperidinium and Anoxemia

ArticleYear
Selective iNOS inhibition attenuates acetylcholine- and bradykinin-induced vasoconstriction in lipopolysaccharide-exposed rat lungs.
    Anesthesiology, 1999, Volume: 91, Issue:6

    Topics: Acetylcholine; Animals; Bradykinin; Dexamethasone; Enzyme Inhibitors; Hypoxia; In Vitro Techniques;

1999